Complement in inflammatory tissue damage and disease (Q58524210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11929126%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Complement in inflammatory tissue damage and disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11929126%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

0 references

Wen-Chao Song

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11929126%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11929126%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11929126%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11929126%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11929126%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

61-64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11929126%20AND%20SRC:MED&resulttype=core&format=json

A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

A critical role for murine complement regulator crry in fetomaternal tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Antibody response to a T-dependent antigen requires B cell expression of complement receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

A role for the C3a anaphylatoxin receptor in the effector phase of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Predominant role for C5b-9 in renal ischemia/reperfusion injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Effects of complement activation in the isolated heart. Role of the terminal complement components

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Synthetic peptides which inhibit the interaction between C1q and immunoglobulin and prolong xenograft survival

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

C1-inhibitor: an anti-inflammatory reagent with therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Inhibition of Heparin/Protamine Complex-Induced Complement Activation by Compstatin in Baboons

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Protective effects of C5a blockade in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902129-9

7 January 2021

10.1016/S1471-4906(01)02129-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11929126%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference